NHLD Stock News 0.4900 05/08/2014 11:41:50 National Holdings

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
National Holdings (NHLD) 0.4900 $NHLD

National Holdings Corporation to Report Fiscal Second Quarter 2014 Financial Results
Business Wire - Mon May 05, 3:42PM CDT
National Holdings Corporation (OTC BB: NHLD) ("National Holdings" or the "Company" today announced that it will host a teleconference to discuss the Company's fiscal second quarter 2014 financial results at 5:00 p.m. ET on Tuesday, May 13, 2014. National Holdings will release its 2014 fiscal second quarter financial results after the market closes on May 13, 2014.

Orchid Island Capital Announces Closing of Sale of Shares Pursuant to Full Exercise of Underwriters' Overallotment Option
GlobeNewswire - Fri Apr 11, 4:20PM CDT
Orchid Island Capital, Inc. (the "Company" (NYSE MKT:ORC) announced today the closing of the sale of 480,000 shares of its common stock for net proceeds of $5,696,640 pursuant to the full exercise of the underwriters' overallotment option granted in connection with the Company's public offering that closed on March 24, 2014. All of the shares in the public offering, including the shares sold pursuant to the overallotment option, were offered by the Company. The shares are listed in the NYSE MKT under the symbol "ORC."

Box Ships Inc. Prices Public Offering of Common Shares and Warrants
PR Newswire - Thu Apr 10, 8:27AM CDT
Box Ships Inc. (NYSE:TEU) (the "Company" today announced that it has priced its public offering of 5,000,000 units consisting of its common shares and warrants at $2.05 per unit. Each unit consists of one common share and a warrant to purchase 0.40 common shares.

Orchid Island Capital Closes Public Offering of Common Stock
GlobeNewswire - Mon Mar 24, 1:53PM CDT
Orchid Island Capital, Inc. (the "Company" (NYSE MKT:ORC) announced that it closed its previously announced public offering of 3,200,000 shares of common stock at a public offering price of $12.55 per share earlier today. All of the shares in the public offering were offered by the Company. The shares are listed in the NYSE MKT under the symbol "ORC".

National Securities adds John Benda as senior equity research analyst
M2 - Thu Mar 20, 4:49AM CDT
National Holdings Corporation (OTC BB:NHLD), a full-service investment banking and asset management firm, disclosed on Wednesday that John R Benda has joined its broker-dealer subsidiary National Securities Corporation as a senior equity research analyst.

ZBB Energy Corporation Announces Successful Completion of Public Offering of Common Stock Including Full Exercise of Over Allotment
Marketwire - Wed Mar 19, 9:14AM CDT
ZBB Energy Corporation (NYSE MKT: ZBB), today announced that it has completed its previously announced underwritten public offering of common stock at a price to the public of $2.25 per share.

Orchid Island Capital Prices Public Offering of Common Stock
GlobeNewswire - Wed Mar 19, 7:58AM CDT
Orchid Island Capital, Inc. (the "Company" (NYSE MKT:ORC) announced today the pricing of its public offering of 3,200,000 shares of common stock at $12.55 per share. The offering is expected to close on March 24, 2014. The Company has granted the underwriters a 30-day option to purchase up to an additional 480,000 shares of common stock on the same terms and conditions to cover over-allotments, if any. All of the shares in the public offering are being offered by the Company.

National Securities Corporation Announces the Addition of John Benda to Equity Research Team
Business Wire - Wed Mar 19, 7:01AM CDT
National Holdings Corporation (OTC BB:NHLD) ("National Holdings" or the "Company", a full-service investment banking and asset management firm, today announced that John R. Benda has joined the Company's broker-dealer subsidiary, National Securities Corporation, as a Senior Equity Research Analyst, covering REITs and other real estate related securities. In the new role, Mr. Benda is based in New York.

ZBB Energy Corporation Announces Pricing of Public Offering of Common Stock
Marketwire - Fri Mar 14, 7:28AM CDT
ZBB Energy Corporation (NYSE MKT: ZBB) (the "Company", a leading developer of intelligent, renewable energy power platforms and hybrid vehicle control systems, today announced the pricing of its previously announced underwritten public offering. The Company is offering 5,500,000 registered shares of its common stock, par value $0.01 per share, at a price to the public of $2.25 per share. In connection with the offering, the Company has also granted the underwriter a 30-day option to purchase up to an additional 825,000 shares of common stock from the Company to cover over-allotments, if any.

ZBB Energy Corporation Announces Proposed Public Offering of Common Stock
Marketwire - Thu Mar 13, 3:05PM CDT
ZBB Energy Corporation (NYSE MKT: ZBB) (the "Company", a leading developer of intelligent, renewable energy power platforms and hybrid vehicle control systems, today announced that it is proposing to offer shares of its common stock in an underwritten public offering. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The final terms of the offering will depend on market and other conditions at the time of pricing, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Neptune Announces Closing of the Over-Allotment Option Associated with its Recently Completed Public Offering of Common Shares
PR Newswire - Thu Mar 06, 10:53AM CST
Neptune Technologies & Bioressources Inc. ("Neptune" (NASDAQ.NEPT - TSX.NTB), announced today that the syndicate of underwriters led by of Euro Pacific Canada Inc. and Roth Capital Partners, as Joint Book-Running Managers, and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD) as Lead Manager, have exercised in full the over-allotment option to purchase an additional 1,500,000 common shares of Neptune at a price of US$2.50 per common share in connection with Neptune's previously announced public offering, completed on March 5, 2014. As a result of the exercise of the over-allotment option, Neptune received additional gross proceeds of US$3.75 million for total gross proceeds of US$28.75 million.

Iroquois Capital Delivers Letter to National Holdings Corporation
PR Newswire - Thu Mar 06, 7:12AM CST
Iroquois Capital Management, LLC (together with its affiliates, "Iroquois", one of the largest shareholders of National Holdings Corporation ("OTC BB: NHLD" or the "Company" with beneficial ownership of approximately 5.9% of the outstanding common stock of the Company, today announced that it has delivered a letter to the Company's Chief Executive Officer, Mark Klein, and the members of the Company's Board of Directors.

Neptune Announces Closing of US$25.0 Million Underwritten Offering of Common Shares
CNW Group - Wed Mar 05, 8:11AM CST
Neptune Technologies & Bioressources Inc. ("Neptune" (NASDAQ.NEPT - TSX.NTB), a biotechnology company engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids, announced today the closing of its previously announced public offering of 10,000,000 common shares at US$2.50 per common share for gross proceeds of US$25.0 million. Euro Pacific Canada Inc. and Roth Capital Partners, LLC acted as Joint Book-Running Managers for the offering and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD), acted as Lead Manager.

National Holdings Posts Fiscal 1st Quarter 2014 Results
Close-Up Media - Thu Feb 20, 11:32PM CST
National Holdings Corp., a full-service investment banking and asset management firm, announced financial results for the Company's fiscal first quarter ended December 31, 2013.

National Holdings Corporation Reports Fiscal First Quarter 2014 Results
Business Wire - Tue Feb 18, 7:00AM CST
National Holdings Corporation (OTCBB:NHLD) ("National Holdings" or the "Company", a full-service investment banking and asset management firm, today announced financial results for the Company's fiscal first quarter ended December 31, 2013.

ZOFT Produces Custom Range of Sweet Candy Gifts for Sweethearts This Valentine's Day
M2 - Fri Feb 14, 3:12AM CST
ZOFT create Gum, Mints, Candy and Confections for suppliers around the world, and is offering heart-shaped special orders to help brands cash in when love is in the air.

National Holdings Corporation to Report Fiscal First Quarter 2014 Financial Results
Business Wire - Thu Feb 13, 7:00AM CST
National Holdings Corporation (OTC BB:NHLD) ("National Holdings" or the "Company" today announced that it will host a teleconference to discuss the Company's fiscal first quarter 2014 financial results at 10:00 a.m. ET on Tuesday, February 18, 2014. National Holdings will release its 2014 fiscal first quarter financial results prior to the market open on February 18, 2014.

Peregrine Pharmaceuticals Prices Offering of Its Series E Preferred Stock
Marketwire - Tue Feb 11, 7:03AM CST
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (the "Company", announced today that it has priced an underwritten public offering of 700,000 shares of its 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock" at a public offering price of $25.00 per share. Holders of Series E Preferred Stock may convert their shares, in whole or in part, into shares of the Company's common stock at a conversion price of $3.00 per share. Gross proceeds to the Company are expected to be approximately $17.5 million ($20.1 million if the option described below is exercised in full) before deducting the underwriting discount and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 19, 2014, subject to the satisfaction of customary closing conditions. The Company has also granted the underwriters an option to purchase up to an aggregate of 105,000 additional shares of its Series E Preferred Stock offered in the public offering, exercisable for 30 days. The Company intends to use the net proceeds from the offering for general corporate purposes. The Company has filed an application to list the shares of Series E Preferred Stock on the NASDAQ Capital Market under the symbol "PPHMP". If approved by NASDAQ, trading of the Series E Preferred Stock on the NASDAQ is expected to begin within 30 days after the date of initial issuance of the Series E Preferred Stock. MLV & Co. LLC is acting as sole book-runner. Maxim Group LLC and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (OTCBB: NHLD), are acting as lead managers for the offering and Empire Asset Management and I-Bankers Securities, Inc. are acting as co-managers for the offering. Roth Capital Partners, LLC and Piper Jaffray & Co. served as financial advisors to Peregrine.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fed Holds Steady, But CD Rates Climb: Savers' Edge

Updated Category News Views 121

The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...

Continue Reading
CaringKind Merger Expands Alzheimer's Care in NY

Updated Category News Views 19

A New Chapter for Dementia Care: The CaringKind Merger Cornerstone local relationships plus a fresh westerly breeze of national presence—that's the gist of the recent union between CaringKind and Alzheimer's Disease Resource Center. This isn't just a big deal for families in Nassau and Suffolk counties, it's a seismic shift for dementia care reaching across state...

Continue Reading
Cat Financial Shows Solid Q3 Growth Amid Challenges

Updated Category News Views 82

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

Continue Reading
CallRail's New Insight Tool: Navigating the Competitive Landscape

Updated Category News Views 11

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Continue Reading
Celebrate Dr. David Neff's Healthcare Legacy

Updated Category News Views 77

An Icon in Medicine and Innovation Dr. David R. Neff's recognition as a Pinnacle Lifetime Member marks a storied journey through medicine and healthcare innovation. Decades of Dedication to Patient Care For over 45 years, Neff carved out a niche in medicine that few can parallel. His overarching focus on infectious disease, cancer, and more represents a holistic approach...

Continue Reading
Busch Gardens' Holiday Extravaganza Lights Up 2026

Updated Category News Views 8

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Continue Reading
AST SpaceMobile Suit Seeks Lead Plaintiff by November 13

Updated Category News Views 86

The Legal Rigmarole The market's got its knickers in a twist over AST SpaceMobile, folks. If you've been dabbling in NASDAQ:ASTS between March '25 and mid-July '26, it's time to perk up those ears. The legal eagles at Robbins Geller Rudman & Dowd LLP are rallying the troops for a class action lawsuit with you front and center. Deadline's looming on November 13, 2026, for...

Continue Reading
Bulletproof Gets Nod for AI Expertise, Eyes Future Growth

Updated Category News Views 0

Bulletproof's Recognition: A Sign of AI Prowess Let's dive right into today's news: Bulletproof just snagged a spot on the 2026 CRN AI Innovators list. Now, this is big leagues stuff, especially since this list highlights the top dogs in the AI space across North America. We're talking about managed service providers, value-added resellers, and all those tech wizards who...

Continue Reading
Unpacking NOMMA's Unique Blend of Education Strategies

Updated Category News Views 41

Introducing NOMMA's Unique Approach Well, here’s one for the books—an educational model that smacks of good ol’ discipline and sharpens minds for what's beyond the classroom. Located in New Orleans, the Military and Maritime Academy, or NOMMA if you want to keep things snappy, serves up an education with a difference. Not only does it prepare cadets academically,...

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 62

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Deckers Outdoor Adjusts to Split with New Price Target Set

Updated Category News Views 50

Deckers Outdoor Stock Price Target Update Recently, Evercore ISI made headlines by revising its price target for the shares of Deckers Outdoor (NYSE: DECK), adjusting it down to $183 from the previous level of $1,100. This reduction, while significant, comes after the company undertook a 6-for-1 stock split, a move aimed at making the stock more appealing to investors....

Continue Reading
Celebrating Exceptional Women in Financial Advisory Services

Updated Category News Views 278

Recognizing Talented Women in Financial Advisory It is with great pleasure that Spectrum Investment Advisors announces significant achievements within its team. Suzanne (Sue) Weeden and Emily Zimmerman have both been honored on the prestigious National Association of Plan Advisors (NAPA) Top Women Advisors List for the year 2025. This recognition emphasizes not just the...

Continue Reading
Analysts Adjust Projections for GE Aerospace's Q2 Earnings

Updated Category News Views 95

Analysts Upgrade Expectations for GE Aerospace’s Earnings GE Aerospace is on the verge of reporting its second quarter earnings, and there is much to anticipate. Analysts are observing closely, with expectations set high for the company, specifically regarding its profitability and revenue generation. This esteemed aerospace segment is amidst a significant growth phase,...

Continue Reading
Innovative Health Care Initiative Launched for Students

Updated Category News Views 292

New Health Care Program for Students The Inland Empire Health Plan (IEHP), along with the California Community College system and the San Bernardino Community College District (SBCCD), has introduced a transformative health care access program aimed specifically at college students. This innovative initiative, titled the Inland Empire Health Plan Equitable Support...

Continue Reading
Rallybio’s Breakthroughs in HPP Treatment and Clinical Advancements

Updated Category News Views 115

Rallybio Corp. (NASDAQ:RLYB) grabbed attention back in 2024 with its hypophosphatasia (HPP) treatment data, leaving desks buzzing about potential outcomes. Analysts at H.C. Wainwright reiterated a Buy rating, slapping a $6.00 price target on the stock based on the company’s compelling data from non-clinical studies showing ENPP1 inhibition's prospects for tackling this...

Continue Reading